Unknown

Dataset Information

0

Does ?-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?


ABSTRACT: ?-Synuclein gene (SNCA) multiplications cause familial parkinsonism and allele-length polymorphisms within the SNCA dinucleotide repeat REP1 increase the risk for developing Parkinson's disease (PD). Since SNCA multiplications increase SNCA expression, and REP1 genotypes that increase the risk of developing PD show increased SNCA expression in cell-culture systems, animal models, and human blood and brain, PD therapies seek to reduce SNCA expression. We conducted an observational study of 1098 PD cases to test the hypothesis that REP1 genotypes correlated with reduced SNCA expression are associated with better motor and cognitive outcomes. We evaluated the association of REP1 genotypes with survival free of Hoehn and Yahr stages 4 or 5 (motor outcome) and of Modified Telephone Interview for Cognitive Status score ?27 or Alzheimer's Disease Dementia Screening Interview score ?2 (cognitive outcome). Median disease duration at baseline was 3.3 years and median lag time from baseline to follow-up was 7.8 years. Paradoxically, REP1 genotypes associated with increased risk of developing PD and increased SNCA expression were associated with better motor (HR = 0.87, p = 0.046, covariate-adjusted age-scale analysis; HR = 0.85, p = 0.020, covariate-adjusted time-scale analysis) and cognitive outcomes (HR = 0.90, p = 0.12, covariate-adjusted age-scale analysis; HR = 0.85, p = 0.023, covariate-adjusted time-scale analysis). Our findings raise the possibility that SNCA has a dual, opposing, and time-dependent role. This may have implications for the development of therapies that target SNCA expression.

SUBMITTER: Markopoulou K 

PROVIDER: S-EPMC4723426 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Markopoulou Katerina K   Biernacka Joanna M JM   Armasu Sebastian M SM   Anderson Kari J KJ   Ahlskog J Eric JE   Chase Bruce A BA   Chung Sun Ju SJ   Cunningham Julie M JM   Farrer Matthew M   Frigerio Roberta R   Maraganore Demetrius M DM  

Parkinsonism & related disorders 20140305 6


α-Synuclein gene (SNCA) multiplications cause familial parkinsonism and allele-length polymorphisms within the SNCA dinucleotide repeat REP1 increase the risk for developing Parkinson's disease (PD). Since SNCA multiplications increase SNCA expression, and REP1 genotypes that increase the risk of developing PD show increased SNCA expression in cell-culture systems, animal models, and human blood and brain, PD therapies seek to reduce SNCA expression. We conducted an observational study of 1098 P  ...[more]

Similar Datasets

| S-EPMC7171193 | biostudies-literature
| S-EPMC3397145 | biostudies-literature
| S-EPMC8558257 | biostudies-literature
2015-06-01 | GSE57475 | GEO
| S-EPMC4917865 | biostudies-literature
| S-EPMC4923719 | biostudies-literature
| S-EPMC6087878 | biostudies-literature
| S-EPMC8194081 | biostudies-literature
| S-EPMC10115881 | biostudies-literature
2014-12-19 | E-GEOD-64304 | biostudies-arrayexpress